Evidence map›Paper›PMID 32222300›Full record

ReviewClinics in geriatric medicine2020

Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update.

Anja Soldan, Corinne Pettigrew, Marilyn Albert

Abstract readReview
In one paragraph

Review in Clinics in geriatric medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Cognitive reserve and everyday functioning in cognitively unimpaired older adults: evidence from the CAN-PROTECT study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  2. Article
  3. The Association Between Multilingual Experience Factors and Cognitive Functioning in Older Adults: A Lifelines Study.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anja SoldanDivision of Cognitive Neuroscience, Department of Neurology, Johns Hopkins School of Medicine, 1620 McElderry Street, Reed Hall West - 1, Baltimore, MD 21205, USA. Electronic address: asoldan1@jhmi.edu.
Corinne PettigrewDivision of Cognitive Neuroscience, Department of Neurology, Johns Hopkins School of Medicine, 1620 McElderry Street, Reed Hall West - 1, Baltimore, MD 21205, USA.
Marilyn AlbertDivision of Cognitive Neuroscience, Department of Neurology, Johns Hopkins School of Medicine, 1620 McElderry Street, Reed Hall West - 1, Baltimore, MD 21205, USA.

Funding

Project 2 MeasurementU19AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI Abhay Moghekar · 2014 to 2026
$51.5M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1985 to 2019
$37.6M
NIA NIH HHS P50 AG005146NIA NIH HHS U19 AG033655
6 · The paper itself

Abstract

The concept of cognitive reserve (CR) was proposed to account for the discrepancy between levels of brain pathologic process or damage and clinical and cognitive function. We provide a detailed review of prospective longitudinal studies that have investigated the interaction between CR and Alzheimer disease (AD) biomarkers on clinical and cognitive outcomes among individuals with normal cognition at baseline. Current evidence is consistent with the view that higher levels of CR are associated with a delay in the onset of symptoms of mild cognitive impairment and that there may be multiple pathways by which CR exerts its protective effects.

Indexed as

Alzheimer DiseaseBrainAgedAsymptomatic DiseasesCognitionCognitive ReserveHumansProtective FactorsAlzheimer diseaseAmyloidAtrophyBiomarkersCognitive reserveMild cognitive impairmentTau

Identifiers

PMID32222300
PMCPMC7837205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.